2025 ahead ayondo Franchise coming soon
Happy 
xMas Holidays
xMas Holidays
xMas Holidays
|
EQS-News: Cannovum Cannabis AG
/ Key word(s): Strategic Company Decision/Personnel
Cannovum Cannabis AG: Full focus on the legalization of cannabis and change in management
Cannovum Cannabis AG (stock exchanges Frankfurt, Xetra, Düsseldorf, Munich, Hamburg, Berlin, Tradegate, gettex: ISIN DE000A2LQU21), one of the leading German cannabis companies traded on the stock exchange, is fully focused on the upcoming legalization of cannabis in Germany. Already, Cannovum Cannabis AG and the Anbau Allianz für Deutschland it co-founded is the partner for politicians, cultivators and the forming cannabis clubs throughout Germany.
As part of this strategic decision, Cannovum Cannabis AG will outsource its existing successful medical business. This will be done under the leadership of founder and board member Pia Marten as part of a management buy-out. Cannovum Cannabis AG continues to hold 25 percent of the company responsible for the medical business, Cannovum Health eG. With the management buy-out, Pia Marten leaves the Management Board of Cannovum Cannabis AG. From now on, the management of Cannovum Cannabis AG is in the hands of the sole CEO Klaus Madzia.
Klaus Madzia: "The legalization of cannabis in Germany is imminent. We see a unique opportunity in this billion-dollar market and are concentrating our forces. The cultivation alliance for Germany founded by Cannovum Cannabis is already the pacesetter for legalization."
Pia Marten: "Cannovum Health eG will focus on the already regulated medical cannabis market. Through new capital brought into the company, we will focus on accelerating the growth of Cannovum Health eG. Especially with the focus on extract distribution we aim for sustainable profitability. I wish Cannovum Cannabis AG under the leadership of Klaus Madzia much success and thank you for the good cooperation."
Contact: Klaus Madzia Board of Directors Cannovum Cannabis AG Phone: +49 30 3982 163 62 E-mail: klaus.madzia@cannovum.com
Cannovum Cannabis AG is the first German fully licensed cannabis company traded on the stock exchange. The shares are traded on the Frankfurt, Xetra, Düsseldorf, Munich, Berlin, Hamburg and gettex stock exchanges. Cannovum Cannabis AG is ready for the legalization of cannabis and well-prepared for this billion dollar market.
19.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Cannovum Cannabis AG |
| Rheinsberger Str. 76/77 | |
| 10115 Berlin | |
| Germany | |
| Phone: | +49 (0)30 3982 16360 |
| E-mail: | klaus.madzia@cannovum.com |
| Internet: | www.cannovum.com |
| ISIN: | DE000A2LQU21 |
| WKN: | A2LQU2 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf (Primärmarkt), Frankfurt, Hamburg, Munich, Tradegate Exchange |
| EQS News ID: | 1660551 |
| End of News | EQS News Service |
|
|
1660551 19.06.2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
